Agency Information Collection Activities; Proposed eCollection, eComments Requested; Revision of a Currently Approved Collection; the National Forensic Laboratory Information System Collection of Drug Analysis Data, 38324-38325 [2018-16740]
Download as PDF
38324
Federal Register / Vol. 83, No. 151 / Monday, August 6, 2018 / Notices
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Cooperative Research
Group on ROS-Industrial Consortium
Americas
Notice is hereby given that, on July
12, 2018, Pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Southwest Research
Institute—Cooperative Research Group
on ROS-Industrial Consortium-Americas
(‘‘RIC-Americas’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Microsoft Corp., Redmond,
WA, has been added as a party to this
venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and RIC-Americas
intends to file additional written
notifications disclosing all changes in
membership.
On April 30, 2014, RIC-Americas filed
its original notification pursuant to
Section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to Section
6(b) of the Act on June 9, 2014 (79 FR
32999).
The last notification was filed with
the Department on June 11, 2018. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on July 9, 2018 (83 FR 31775).
Suzanne Morris,
Chief, Premerger and Division Statistics Unit,
Antitrust Division.
[FR Doc. 2018–16713 Filed 8–3–18; 8:45 am]
BILLING CODE 4410–11–P
DEPARTMENT OF JUSTICE
sradovich on DSK3GMQ082PROD with NOTICES
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Integrated Photonics
Institute for Manufacturing Innovation
Operating Under the Name of The
American Institute for Manufacturing
Integrated Photonics
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Integrated Photonics
Institute for Manufacturing Innovation
operating under the name of the
American Institute for Manufacturing
Integrated Photonics (‘‘AIM Photonics’’)
has filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Applied Materials, Inc.,
Santa Clara, CA; The Board of
Governors of the Colorado State
University System acting by and
through Colorado State University, Fort
Collins, CO; Stonehill College, Inc.,
Easton, MA; University of Chicago
Argonne LLC, as operator of Argonne
National Laboratory, Lemont, IL; The
George Washington University,
Washington, DC; Marktech International
Corporation dba Marktech
Optoelectronics, Latham, NY; and
Israeli Hi-Tech Association at the
Manufacturer’s Association of Israel,
TelAviv, ISRAEL, have been added as
parties to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and AIM
Photonics intends to file additional
written notifications disclosing all
changes in membership.
On June 16, 2016, AIM Photonics
filed its original notification pursuant to
Section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to Section
6(b) of the Act on July 25, 2016 (81 FR
48450).
The last notification was filed with
the Department on January 26, 2018. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on March 12, 2018 (83 FR 10750).
Suzanne Morris,
Chief, Premerger and Division Statistics Unit,
Antitrust Division.
[FR Doc. 2018–16706 Filed 8–3–18; 8:45 am]
BILLING CODE 4410–11–P
Notice is hereby given that, on July
23, 2018, pursuant to Section 6(a) of the
VerDate Sep<11>2014
17:36 Aug 03, 2018
Jkt 244001
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
[OMB Number 1117–0034]
Agency Information Collection
Activities; Proposed eCollection,
eComments Requested; Revision of a
Currently Approved Collection; the
National Forensic Laboratory
Information System Collection of Drug
Analysis Data
Drug Enforcement
Administration, Department of Justice.
ACTION: 30-day Notice.
AGENCY:
The Department of Justice
(DOJ), Drug Enforcement
Administration (DEA), will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection
was previously published in the Federal
Register, on June 11, 2018, allowing for
a 60 day comment period.
DATES: Comments are encouraged and
will be accepted for 30 days until
September 5, 2018.
FOR FURTHER INFORMATION CONTACT: If
you have comments on the estimated
public burden or associated response
time, suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Thomas D. Sonnen, Diversion Control
Division, Drug Enforcement
Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia
22152; Telephone: (202) 598–6812 or
sent to OIRA_submission@omb.eop.gov.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information proposed to be collected
can be enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
SUMMARY:
E:\FR\FM\06AUN1.SGM
06AUN1
Federal Register / Vol. 83, No. 151 / Monday, August 6, 2018 / Notices
sradovich on DSK3GMQ082PROD with NOTICES
appropriate automated, electronic,
mechanical, or other forms of
information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
1. Type of Information Collection:
Revision of a currently approved
collection.
2. Title of the Form/Collection: The
National Forensic Laboratory
Information System Collection of Drug
Analysis Data.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
Medical Examiner/Coroner Office
Survey; National Forensic Laboratory
Information System Drug Survey of
Drug Laboratories; and Toxicology
Laboratory Survey for the component
within the Department of Justice is the
Drug Enforcement Administration,
Diversion Control Division.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Affected public (Primary): Forensic
Science Laboratory Management.
Abstract: The National Forensic
Laboratory Information System (NFLIS)
collections provide the DEA with
national databases on analyzed drug
samples from law enforcement
activities, antemortem toxicology
samples (toxiciology laboratories), and
post-mortem toxicology samples
(medical examiner/coroner offices
(MECs) from federal, state, and local
laboratories. Specifically, NFLIS-Drug
data provide DEA current, precise, and
representative estimates of drugs seized
by law enforcement and analyzed by
forensic laboratories. Since 2001, DEA
has had case and drug report estimates
for all drugs reported in NFLIS that are
statistically representative of the nation
and of census regions. The estimates,
which are made possible by updating
the laboratory profiles through the
survey effort (see draft survey in
Appendix), have given DEA the ability
to track national and regional drug
trends; a clearer national picture of
illicit or diverted drug availability;
additional information about the
temporal changes in drug availability by
geographic region; and the ability to
detect new or emerging drugs.
Information from NFLIS is combined
with other existing databases to develop
more accurate, up-to-date information
on abused drugs. This database
represents a voluntary, cooperative
effort on the part of participating
laboratories and MECs to provide a
centralized source of analyzed drug
VerDate Sep<11>2014
17:36 Aug 03, 2018
Jkt 244001
data. Existing federal drug abuse
databases do not provide the type,
scope, timeliness, or quality of
information necessary to effectively
estimate the actual or relative abuse
potential of drugs as required under the
Controlled Substances Act (21 U.S.C.
811(b)) and international treaties in a
timely and efficient manner. For
example, much of the trafficking data
for federal drug scheduling actions is
presently obtained on a case-by-case
basis from state and local laboratories.
Occasionally scientific personnel from
the DEA’s Diversion Control Division,
Drug and Chemical Evaluation Section,
have contacted specific laboratories and
requested files. In addition, some DEA
field offices routinely subpoena MEC
records for use in case work. The
development of the National Forensic
Laboratory Information System (NFLIS)
greatly enhances the collection of such
data. Submission of information for this
collection is voluntary. DEA is not
mandating this information collection.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: The DEA estimates that 140
persons annually for this collection at
1.6 hour per respondent, for an annual
burden of 218 hours.
6. An estimate of the total public
burden (in hours) associated with the
proposed collection: The DEA estimates
that this collection takes 218 annual
burden hours.
If additional information is required
please contact: Melody Braswell,
Department Clearance Officer, United
States Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE, Suite 3E.405B,
Washington, DC 20530.
Dated: August 1, 2018.
Melody Braswell,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2018–16740 Filed 8–3–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
[OMB Number 1121–NEW]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; New
Collection: Survey of State Attorneys
General Offices (SSAGO): Human
Trafficking
Bureau of Justice Statistics,
Department of Justice.
ACTION: 60-Day notice.
AGENCY:
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
38325
The Department of Justice
(DOJ), Office of Justice Programs,
Bureau of Justice Statistics (BJS), will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until
October 5, 2018.
FOR FURTHER INFORMATION CONTACT: If
you have additional comments
especially on the estimated public
burden or associated response time,
suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Suzanne Strong, Statistician,
Prosecution and Judicial Statistics Unit,
Bureau of Justice Statistics, 810 Seventh
Street NW, Washington, DC 20531
(email: Suzanne.M.Strong@usdoj.gov;
telephone: 202–616–3666).
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the Bureau of Justice
Statistics, including whether the
information will have practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
SUMMARY:
Overview of This Information
Collection
(1) Type of Information Collection:
New collection.
(2) The Title of the Form/Collection:
Survey of State Attorneys General
Offices (SSAGO)—Human Trafficking.
(3) The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
SSAGO–2. The applicable component
E:\FR\FM\06AUN1.SGM
06AUN1
Agencies
[Federal Register Volume 83, Number 151 (Monday, August 6, 2018)]
[Notices]
[Pages 38324-38325]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-16740]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
[OMB Number 1117-0034]
Agency Information Collection Activities; Proposed eCollection,
eComments Requested; Revision of a Currently Approved Collection; the
National Forensic Laboratory Information System Collection of Drug
Analysis Data
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: 30-day Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Justice (DOJ), Drug Enforcement
Administration (DEA), will be submitting the following information
collection request to the Office of Management and Budget (OMB) for
review and approval in accordance with the Paperwork Reduction Act of
1995. The proposed information collection was previously published in
the Federal Register, on June 11, 2018, allowing for a 60 day comment
period.
DATES: Comments are encouraged and will be accepted for 30 days until
September 5, 2018.
FOR FURTHER INFORMATION CONTACT: If you have comments on the estimated
public burden or associated response time, suggestions, or need a copy
of the proposed information collection instrument with instructions or
additional information, please contact Thomas D. Sonnen, Diversion
Control Division, Drug Enforcement Administration; Mailing Address:
8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (202)
598-6812 or sent to [email protected].
SUPPLEMENTARY INFORMATION: Written comments and suggestions from the
public and affected agencies concerning the proposed collection of
information are encouraged. Your comments should address one or more of
the following four points:
--Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of
the information proposed to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are
to respond, including through the use of
[[Page 38325]]
appropriate automated, electronic, mechanical, or other forms of
information technology, e.g., permitting electronic submission of
responses.
Overview of This Information Collection
1. Type of Information Collection: Revision of a currently approved
collection.
2. Title of the Form/Collection: The National Forensic Laboratory
Information System Collection of Drug Analysis Data.
3. The agency form number, if any, and the applicable component of
the Department sponsoring the collection: Medical Examiner/Coroner
Office Survey; National Forensic Laboratory Information System Drug
Survey of Drug Laboratories; and Toxicology Laboratory Survey for the
component within the Department of Justice is the Drug Enforcement
Administration, Diversion Control Division.
4. Affected public who will be asked or required to respond, as
well as a brief abstract:
Affected public (Primary): Forensic Science Laboratory Management.
Abstract: The National Forensic Laboratory Information System
(NFLIS) collections provide the DEA with national databases on analyzed
drug samples from law enforcement activities, antemortem toxicology
samples (toxiciology laboratories), and post-mortem toxicology samples
(medical examiner/coroner offices (MECs) from federal, state, and local
laboratories. Specifically, NFLIS-Drug data provide DEA current,
precise, and representative estimates of drugs seized by law
enforcement and analyzed by forensic laboratories. Since 2001, DEA has
had case and drug report estimates for all drugs reported in NFLIS that
are statistically representative of the nation and of census regions.
The estimates, which are made possible by updating the laboratory
profiles through the survey effort (see draft survey in Appendix), have
given DEA the ability to track national and regional drug trends; a
clearer national picture of illicit or diverted drug availability;
additional information about the temporal changes in drug availability
by geographic region; and the ability to detect new or emerging drugs.
Information from NFLIS is combined with other existing databases to
develop more accurate, up-to-date information on abused drugs. This
database represents a voluntary, cooperative effort on the part of
participating laboratories and MECs to provide a centralized source of
analyzed drug data. Existing federal drug abuse databases do not
provide the type, scope, timeliness, or quality of information
necessary to effectively estimate the actual or relative abuse
potential of drugs as required under the Controlled Substances Act (21
U.S.C. 811(b)) and international treaties in a timely and efficient
manner. For example, much of the trafficking data for federal drug
scheduling actions is presently obtained on a case-by-case basis from
state and local laboratories. Occasionally scientific personnel from
the DEA's Diversion Control Division, Drug and Chemical Evaluation
Section, have contacted specific laboratories and requested files. In
addition, some DEA field offices routinely subpoena MEC records for use
in case work. The development of the National Forensic Laboratory
Information System (NFLIS) greatly enhances the collection of such
data. Submission of information for this collection is voluntary. DEA
is not mandating this information collection.
5. An estimate of the total number of respondents and the amount of
time estimated for an average respondent to respond: The DEA estimates
that 140 persons annually for this collection at 1.6 hour per
respondent, for an annual burden of 218 hours.
6. An estimate of the total public burden (in hours) associated
with the proposed collection: The DEA estimates that this collection
takes 218 annual burden hours.
If additional information is required please contact: Melody
Braswell, Department Clearance Officer, United States Department of
Justice, Justice Management Division, Policy and Planning Staff, Two
Constitution Square, 145 N Street NE, Suite 3E.405B, Washington, DC
20530.
Dated: August 1, 2018.
Melody Braswell,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2018-16740 Filed 8-3-18; 8:45 am]
BILLING CODE 4410-09-P